ARTIFICIAL INTELLIGENCE IS REVOLUTIONIZING PATHOLOGY
Data powered
pathology
Advanced pathology for preclinical research, clinical trials, and decision support
Pathology INTELLIGENCE
Advancing Research, Improving Patient Outcomes
What we do
Biopharma Services
Take advantage of our high quality histopathology research services to generate quantitative pathology end points.
imageDx
Access the the most advanced AI-powered digital assay pathology platform in the cloud.
Clinical Decision Support
Incorporate AI-powered pathology decision support tools to improve patient outcomes.
Pathology Powered By
DATA
Innovative Technology
Quantitative IHC
High quality immunohistochemistry (IHC) combined with whole slide imaging and cell-by-cell quantification to advance your research.
imageDx: NASH
Access the most advanced quantitative NASH and fibrosis data from your human or rodent liver samples.
Trusted By The World's Leading Scientists
Data powered pathology for advanced research & better patient care
News & Articles
Latest research, in the news, or at events.
Multiplex Assays for Spatial Biology: An Interview with Dr. Christopher Kerfoot
We sat down with Dr. Christopher Kerfoot, Global Strategic Advisor of Histopathology at CellCarta & Co-founder of Mosaic Laboratories, who provided an in-depth examination of the cutting-edge multiplex technology
CellCarta Launches Advanced AI-Powered Spatial Biology Data for Clinical Trials
LAKE FOREST, CA, March 1st, 2022 – CellCarta, a global provider of precision medicine services, announced today the launch of imageDx PRISM to significantly advance the spatial biology data
Reveal Biosciences Joins the CellCarta Family
CellCarta Strengthens its Histological Biomarker Franchise by Acquiring Artificial Intelligence-Based Quantitative Pathology Leader Reveal Biosciences MONTREAL, Canada, May 11th, 2021 / CNW – CellCarta, a global provider of precision
